Paravalvular Abscess as a Complication of Streptococcus Salivarius Infective Endocarditis of a Bioprosthetic Aortic Valve

Gil Hevroni¹, Andrii Maryniak¹, Diego Cepeda-Mora¹, Moro O. Salifu¹ and Samy I. McFarlane^1,

¹Department of Internal Medicine, SUNY-Downstate Health Science University, Brooklyn, New York, United States-11203

Cite this paper:
Gil Hevroni, Andrii Maryniak, Diego Cepeda-Mora, Moro O. Salifu and Samy I. McFarlane. Paravalvular Abscess as a Complication of Streptococcus Salivarius Infective Endocarditis of a Bioprosthetic Aortic Valve. American Journal of Medical Case Reports. 2020; 8(11):405-408. doi: 10.12691/ajmcr-8-11-7

Abstract

Rates of implantation of prosthetic valves and cardiac devices have increased significantly in the last thirty years, accounting, at least in-part, for the growing incidence of infective endocarditis cases. Prosthetic valve endocarditis (PVE) is an endovascular, microbial infection occurring on parts of a valve prosthesis or on reconstructed native heart valves. We present a case of a 63-year-old man with multiple comorbidities including extensive cardiovascular disease, who recently underwent bioprosthetic aortic valve replacement. Patient presented to the emergency department with exertional chest pain, dyspnea, fever, melena and lethargy. Blood cultures grew Streptococcus salivarius and transesophageal echocardiography confirmed PVE with an aortic paravalvular abscess. The patient was treated with appropriate antimicrobial therapy based on culture sensitivity and subsequently referred to cardiothoracic surgery for urgent evaluation. This case highlights several important points which include but are not limited to: investigation into the pathogen Streptococcus salivarius and its relationship to other known pathogens, understanding of the complications associated with PVE, and the importance of early identification of PVE and initiation of medical and surgical therapy with respect to prognosis.

Keywords:
prosthetic valve endocarditis paravalvular abscess bioprosthetic aortic valve streptococcus salivarius

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Baddour Larry, M., et al. (2015). "Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications." Circulation 132(15): 1435-1486.
[2]	Holland, T. L., et al. (2016). "Infective endocarditis." Nature reviews. Disease primers 2: 16059-16059.
[3]	Glaser, N., et al. (2019). "Loss in Life Expectancy After Surgical Aortic Valve Replacement: SWEDEHEART Study." Journal of the American College of Cardiology 74(1): 26-33.
[4]	Corredoira, J. C., et al. (2005). "Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study." European Journal of Clinical Microbiology and Infectious Diseases 24(4): 250-255.
[5]	Ruoff, K. L., et al. (1989). "Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates." J Clin Microbiol 27(2): 305-308.
[6]	Facklam, R. (2002). "What happened to the streptococci: overview of taxonomic and nomenclature changes." Clinical microbiology reviews 15(4): 613-630.
[7]	Carpenter, J. L. (1990). Perivalvular Extension of Infection in Patients with Infectious Endocarditis. Clinical Infectious Diseases, 13(1), 127-138.
[8]	Ivanovic, B., Trifunovic, D., Matic, S., Petrovic, J., Sacic, D., & Tadic, M. (2019). Prosthetic valve endocarditis - A trouble or a challenge? Journal of Cardiology, 73(2), 126-133.
[9]	Correction to: Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. (2016). Circulation, 134(8).
[10]	Wang, A. (2007). Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis. Jama, 297(12), 1354.
[11]	Thomas, D., Desruennes, M., Jault, F., Isnard, R., & Gandjbakhch, I. (1993). Cardiac and extracardiac abscesses in bacterial endocarditis. Archives Des Maladies Du Coeur Et Des Vaisseaux , 86(12), 1825-1835.
[12]	Barca, L. V., Elorza, E. N., Fernández-Hidalgo, N., Mur, J. L. M., García, A. M., Fernández-Felix, B. M., … López-Menéndez, J. (2019). Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis. Infection, 47(6), 879-895.
[13]	Tao, E., Wan, L., Wang, W., Luo, Y., Zeng, J., & Wu, X. (2017). The prognosis of infective endocarditis treated with biological valves versus mechanical valves: A meta-analysis. Plos One, 12(4).
[14]	Pettersson, G. B., & Hussain, S. T. (2019). Current AATS guidelines on surgical treatment of infective endocarditis. Asvide, 6, 336-336.
[15]	Corredoira, J. C., Alonso, M. P., García, J. F., Casariego, E., Coira, A., Rodriguez, A., … Varela, J. (2005). Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. European Journal of Clinical Microbiology & Infectious Diseases, 24(4), 250-255.